Medicaid plays a vital role in the American healthcare system, providing coverage for millions of vulnerable individuals. To gain a deeper understanding of the program's evolving landscape, its unique strengths, and the challenges it faces, we spoke with Gary Jessee, Senior Vice President, National Consulting. With extensive experience on both the payer and provider sides, Jessee offers valuable insights into Medicaid's role in addressing critical needs, from long-term services and supports to
Read More
Health IT, Digital Health Interviews | Q/A - HIT Consultant
Q/A: Unpacking the Power of WiFi 7 for Healthcare with Wyebot CEO Roger Sands
What You Should Know:
The landscape of healthcare is increasingly digital, relying on a robust and reliable network infrastructure to support everything from patient monitoring to advanced medical imaging. The latest generation of WiFi technology, WiFi 7, promises a significant leap forward in capacity, speed, and latency. To delve deeper into the transformative potential of WiFi 7 for hospitals and health systems, we had the opportunity to speak with Roger Sands, CEO and co-founder of
Read More
Healthcare M&A Slowdown 2024: Alvarez & Marsal’s Raheel Khan on Market Challenges & 2025 Outlook
In 2024, the healthcare mergers and acquisitions (M&A) landscape experienced a notable slowdown, leaving industry stakeholders pondering the contributing factors and anticipating future trends. To shed light on this complex scenario, we sat down with Raheel Khan, Managing Director at Alvarez & Marsal Transaction Advisory Group. With extensive experience advising both buyers and sellers in the healthcare sector, Khan offers valuable insights into the forces shaping M&A activity, the
Read More
Overprescribing and Polypharmacy: Arine CEO Talks The Hidden Dangers of Amazon’s Same-Day Prescription Delivery
As ultra-fast prescription delivery services reshape medication access, healthcare providers face an urgent challenge: balancing patient convenience with medication safety. With 1 in 5 adults using five or more prescription drugs and medication-related problems consuming 1 in 6 healthcare dollars ($528B annually), the stakes are high.
In this interview, Yoona Kim, CEO of healthcare AI company Arine discusses how the evolution of prescription delivery services, while improving access, may
Read More
Q/A: Cedar Exec Talks The Untapped Potential of AI in Healthcare Call Centers in 2025
What if AI could dramatically reduce call volume, improve patient satisfaction, and empower your call center staff? In this exclusive interview, Dugan Winkie, Head of Commercial Strategy at Cedar, sheds light on the often-overlooked opportunity of leveraging AI in healthcare call centers.
Winkie explores the unique challenges and opportunities AI presents for providers, highlighting the potential for increased efficiency, improved patient experiences, and significant financial gains. He
Read More
Vorro CEO Talks Bridging the Interoperability Gap in Healthcare
Despite government mandates and advancements in technology, EHR interoperability remains a significant challenge for clinicians. A recent KLAS report highlighted widespread dissatisfaction with external data integration, hindering efficient care delivery and contributing to clinician burnout.
In this exclusive interview, Scott Sirdevan, CEO of Vorro, a leading provider of no-code data integration solutions, provides expert insights into the complexities of interoperability in healthcare. He
Read More
Q/A: Funding Landscape: IPO or Buyout for Life Science Companies?
Life science companies, particularly those heavily invested in research and development, often face critical funding decisions. Should they pursue an initial public offering (IPO) to fuel their growth, or is a strategic buyout from a larger company a more suitable path?
In this exclusive interview, Taylor Wirth, a partner at Barnes & Thornburg, offers his insights on evaluating market conditions, assessing company readiness, and weighing the pros and cons of each funding option. He
Read More
Q/A: Medidata VP Talks Overcoming Financial Barriers to Diversity in Clinical Trials
Achieving diversity in clinical trials is crucial for developing effective and safe treatments for all populations. Yet, financial barriers often exclude underrepresented groups from participating, hindering progress towards health equity. This disparity raises critical questions about the accessibility and inclusivity of medical research.
In this insightful Q&A, Meghan Harrington, VP of Clinical Trial Financial Management at Medidata, a Dassault Systèmes brand, sheds light on the
Read More
Q/A: Proscia Co-Founder Talks Impact of DICOM in Digital Pathology
The world of digital pathology is undergoing a significant transformation, with the adoption of DICOM (Digital Imaging and Communications in Medicine) emerging as a game-changer. This international standard, already widely used in radiology, is poised to transform how pathology images and data are stored, shared, and analyzed.
By promoting interoperability among various hardware and software solutions, DICOM empowers laboratories to build more efficient and scalable digital pathology
Read More
Q/A: Vim CEO Talks Solving the Rising Tide of Healthcare Claim Denials
The U.S. healthcare system is grappling with a surge in claim denials and prior authorization requirements, creating significant challenges for both providers and patients. To shed light on this pressing issue, we spoke with Oron Afek, CEO of Vim, a company that assists over 20,000 providers and 80% of the largest U.S. payers with prior authorizations.
In this interview, Oron Afek provides valuable insights into the challenges and potential solutions related to claim denials and prior
Read More
